NCT03599102

Brief Summary

LOVED stands for the Living Organ Video Educated Donors (LOVED) program. It is a culturally tailored program for African Americans to reduce the disparity of low rates of living kidney donation. It is a mobile health delivered platform that does not require transplant center visits, thus increasing the reach of the program compared to center-based program to enhance living kidney donation. The purpose of LOVED is to give education and encouragement to those who need a kidney transplant and teach about the process of living donation to be better educated when approaching others about donating a kidney. The ultimate goal of the program is to increase the number of living kidney donor transplants, especially among African Americans in South Carolina. The program was created to educate those in need of a kidney about the donor process, to dispel myths about living donation, discuss who can be asked to donate and develop and practice skills to start asking others for a living kidney donation. The program is designed to be completed using a tablet computer and is made up of weekly video education clips, resources, short quizzes to reinforce the learning points and weekly video chat sessions with others who need a kidney led by a "navigator" who was once a living donor kidney recipient. The video clips are made up of stories and brief educational messages from transplant center staff, physicians, former donors and recipients. The video chat sessions were designed to solve and address individual issues for those enrolled in the program and to give a sense of community as they continue on their journey to find a kidney. This randomized control trial uses groups of 6-9 participants in each LOVED group that lasts 8-weeks each. A total of 60 participants will be recruited with 30 assigned to LOVED and 30 assigned to a standard care groups. This program is funded by a grant from the National Institute of Health and was developed at the Medical University of South Carolina.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 1, 2016

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
6 months until next milestone

First Posted

Study publicly available on registry

July 26, 2018

Completed
Last Updated

May 18, 2021

Status Verified

May 1, 2021

Enrollment Period

8 months

First QC Date

December 1, 2016

Last Update Submit

May 14, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • Participant adherence to study protocols

    Tolerability as defined by % retention to study (% of participants who self-remove from the study) Fidelity as defined by %adherence to chat sessions and completion %of video modules.

    Assessed at 8 weeks

  • Change in knowledge about living donation

    Score measures for self-efficacy, knowledge and attitudes to approach others to be a living donor -LDKT Knowledge Scale (knowledge) (15 item T/F); each correct response adds 1 point. 0-15 range with higher numbers represent higher knowledge.

    Change between 0 and 8 weeks and change between 0 and 6 months

  • Change in attitudes on living donation

    LDKT Concerns Scale (i.e., measuring attitudes) (21 T/F with one point for each statement suggestive of more worry); 0-21 range with higher results representing more concerns about LDKT.

    Change between 0 and 8 weeks and change between 0 and 6 months

  • Change in self-efficacy to ask others to be a living donor

    Willingness to Discuss LDKT Scale (i.e., measuring self-efficacy (SE)) (1 item each for family, friends, and strangers7 pt. Likert scale) 1-7 range with higher values representing higher SE to approach others about living donation

    Change between 0 and 8 weeks and change between 0 and 6 months

Secondary Outcomes (1)

  • Completing living donor kidney transplantation

    8 weeks, 6 months

Other Outcomes (4)

  • Assessment of making autonomous decisions

    8 weeks

  • Assessment of feelings of trust

    8 weeks

  • Assessment of cultural competency

    8 weeks

  • +1 more other outcomes

Study Arms (2)

LOVED intervention

EXPERIMENTAL

Intervention group receives the LOVED program, an 8-week program where participants receive video education modules, and weekly video chat sessions with other end-stage renal disease patients and a prior living kidney African American recipient. The program aims to increase knowledge and skills on how to promote individual strategies on how to ask for a kidney from others.

Behavioral: LOVED Intervention

Standard Care

NO INTERVENTION

Standard interaction with transplant center and physician care.

Interventions

LOVED intervention

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old
  • African American
  • Legally competent
  • Able to read and speak in English
  • Able to use tablet computers (after instruction)
  • Able to use cell phone
  • years or less on the kidney waitlist with active status including pre-emptive and ESRD patients on dialysis
  • years or less on dialysis

You may not qualify if:

  • Patients who have currently identified PDs moving through the evaluation stage

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

Location

Study Officials

  • Frank A Treiber, PhD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR
  • Baliga Baliga, MD

    Medical University of South Carolina

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 1, 2016

First Posted

July 26, 2018

Study Start

August 1, 2016

Primary Completion

April 1, 2017

Study Completion

February 1, 2018

Last Updated

May 18, 2021

Record last verified: 2021-05

Data Sharing

IPD Sharing
Will not share

Locations